Veerhealth Care share news, announcements and annual reports
BSE: 511523Pharmaceuticals & BiotechnologySmall Cap
Veerhealth Care Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1994
Last close ₹48.38down ₹0.61 (1.25%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹48.99.
30 Oct: open ₹49.48, high ₹49.48, low ₹48.00
52-week range of traded prices to 30 Oct 2026
₹16.70Low, 1 Feb 2026₹52.00High, 15 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹97 Cr3,569th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 63.23
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.31 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 52.58
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.22
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.31 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 8.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,65,871
Veerhealth Care board meetings
126 filed, newest first. Page 2 of 3.
Feb 2023
6 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Dec 2022
5 Dec · Board meeting
Nov 2022
28 Nov · Board meeting
Meeting on 5 Dec 2022: preferential issue of shares14 Nov · Board meeting
Meeting on 23 Nov 2022: preferential issue of shares10 Nov · Board meeting
1 Nov · Board meeting
Meeting on 10 Nov 2022: quarterly results
Aug 2022
4 Aug · Board meeting
Meeting on 12 Aug 2022: annual general meeting and quarterly results
May 2022
20 May · Board meeting
Meeting on 30 May 2022: audited results
Feb 2022
3 Feb · Board meeting
Meeting on 11 Feb 2022: voluntary delisting of shares and quarterly results
Nov 2021
1 Nov · Board meeting
Meeting on 12 Nov 2021: quarterly results
Aug 2021
5 Aug · Board meeting
Meeting on 13 Aug 2021: quarterly results and annual general meeting
Jun 2021
22 Jun · Board meeting
Meeting on 30 Jun 2021: audited results
Jan 2021
19 Jan · Board meeting
Meeting on 28 Jan 2021: quarterly results
Nov 2020
2 Nov · Board meeting
Meeting on 10 Nov 2020: quarterly results
Aug 2020
26 Aug · Board meeting
Meeting on 2 Sep 2020: quarterly results and annual general meeting
Jul 2020
Jun 2020
24 Jun · Board meeting
Meeting on 30 Jul 2020: audited results and dividend23 Jun · Board meeting
Meeting on 30 Jun 2020: audited resultsNot held on this date
Feb 2020
4 Feb · Board meeting
Meeting on 12 Feb 2020: quarterly results
Nov 2019
4 Nov · Board meeting
Meeting on 14 Nov 2019: quarterly results
Aug 2019
5 Aug · Board meeting
Meeting on 13 Aug 2019: annual general meeting and quarterly results
Jul 2019
May 2019
16 May · Board meeting
Meeting on 28 May 2019: audited results